HB5708: MCM PRV Reauthorization Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats.
Plain-language summary
This bill would extend a priority review program under federal drug law for treatments targeting agents that threaten national security. The program speeds up the FDA's review of new drugs, allowing faster approval for medications addressing serious threats. The bill amends existing federal food and drug law and is currently in the introductory stage in Congress. It was sponsored by Representatives Brad Finstad and Dean Phillips.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB5708: MCM PRV Reauthorization Act